Clinical trial of KIB-PCI in healthy Japanese children

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222503

Enrollment

150

Registered

2014-05-29

Start date

2014-05-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis of new type of influenza infection

Interventions

investigational material(s) Generic name etc : KIB-PCI (H5N1 influenza vaccin) INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy Japanese children

Exclusion criteria

Exclusion criteria: 1) Subjects with history of H5N1 influenza 2) Subjects with history of H5N1 influenza vaccination

Design outcomes

Primary

Measure	Time frame
SRH antibody titer	—

Secondary

Measure	Time frame
Neutralizing antibody titer	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026